Comparing the alpha-galactosidase A biochemical properties from healthy individuals and Fabry disease patients

Clinica Chimica Acta

Volumn 445, Issue , 2015, Pages 60-64

  Daitx, Vanessa Vitcoski ^a   Mezzalira, Jamila ^a   Moraes, Vitória da Costa ^a   Breier, Ana Carolina ^a   Cé, Jaqueline ^a   Coelho, Janice Carneiro ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Alpha galactosidase A; Fabry disease; Kinetics; Lysosomal disorders

Indexed keywords

ALPHA GALACTOSIDASE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRIED BLOOD SPOT TESTING; ENZYME ACTIVITY; ENZYME ASSAY; FABRY DISEASE; FEMALE; HUMAN; INCUBATION TEMPERATURE; LEUKOCYTE COUNT; MALE; MAXIMUM REACTION VELOCITY; MISSENSE MUTATION; MOLECULAR DIAGNOSIS; PH; PHENOTYPE; PRIORITY JOURNAL; THERMOSTABILITY; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME STABILITY; ENZYMOLOGY; HEAT; KINETICS; METABOLISM; MONONUCLEAR CELL; PATHOLOGY;

ALPHA-GALACTOSIDASE; CASE-CONTROL STUDIES; DRIED BLOOD SPOT TESTING; ENZYME STABILITY; FABRY DISEASE; FEMALE; HOT TEMPERATURE; HUMANS; KINETICS; LEUKOCYTES, MONONUCLEAR; MALE;

EID: 84925424572     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.03.014     Document Type: Article

References (33)

1. Desnick R.J., Ioannou Y.A., Eng C.M. Alpha-galactosidase A deficiency: Fabry disease. The metabolic & molecular bases of inherited disease 2001, 3733-3774. McGraw-Hill, New York; London. C.R. Scriver, A.L. Beaudet, W.S. Sly (Eds.).
2. Meikle P.J., Hopwood J.J., Clague A.E., Carey W.F. Prevalence of lysosomal storage disorders. JAMA 1999, 281:249-254.
3. Spada M., Pagliardini S., Yasuda M., et al. High incidence of later-onset Fabry disease revealed by newborn screening. Am J Hum Genet 2006, 79:31-40.
4. Hwu W.L., Chien Y.H., Lee N.C., et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A). Hum Mutat 2009, 30:1397-1405.
5. Wittmann J., Karg E., Turi S., et al. Newborn screening for lysosomal storage disorders in Hungary. JIMD Rep 2012, 6:117-125.
6. Linthorst G.E., Vedder A.C., Aerts J.M., Hollak C.E. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta 2005, 353:201-203.
7. Nakamura K., Hattori K., Endo F. Newborn screening for lysosomal storage disorders. Am J Med Genet C Semin Med Genet 2011, 157:63-71.
8. Civallero G., Michelin K., de Mari J., et al. Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases. Clin Chim Acta 2006, 372:98-102.
9. Chamoles N.A., Blanco M., Gaggioli D. Fabry disease: enzymatic diagnosis in dried blood spots on filter paper. Clin Chim Acta 2001, 308:195-196.
10. de Castilhos C.D., Mezzalira J., Goldim M.P., Coelho J.C. Influence of pre-analytical factors on alpha-galactosidase A, arylsulfatase B and alpha-glucosidase activities measured on dried blood spots on filter paper. Clin Biochem 2011, 44:922-926.
11. Wenger D.A., Coppola S., Liu S.L. Insights into the diagnosis and treatment of lysosomal storage diseases. Arch Neurol 2003, 60:322-328.
12. Germain D.P. Fabry disease. Orphanet J Rare Dis 2010, 5:30.
13. Ishii S., Chang H.H., Kawasaki K., et al. Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem J 2007, 406:285-295.
14. Desnick R.J., Allen K.Y., Desnick S.J., Raman M.K., Bernlohr R.W., Krivit W. Fabry's disease: enzymatic diagnosis of hemizygotes and heterozygotes. Alpha-galactosidase activities in plasma, serum, urine, and leukocytes. J Lab Clin Med 1973, 81:157-171.
15. Daitx V.V., Mezzalira J., Goldim M.P., Coelho J.C. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma. Clin Biochem 2012, 45:1233-1238.
16. Dean K.J., Sweeley C.C. Studies on human liver alpha-galactosidases. I. Purification of alpha-galactosidase A and its enzymatic properties with glycolipid and oligosaccharide substrates. J Biol Chem 1979, 254:9994-10000.
17. Lukas J., Giese A.K., Markoff A., et al. Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in Fabry disease. PLoS Genet 2013, 9:e1003632.
18. Mandelli J., Wajner A., Pires R., Giugliani R., Coelho J.C. Detection of mucopolysaccharidosis type I heterozygotes on the basis of the biochemical properties of plasma alpha-l-iduronidase. Clin Chim Acta 2001, 312:81-86.
19. Mandelli J., Wajner A., Pires R.F., Giugliani R., Coelho J.C. Detection of mucopolysaccharidosis type I heterozygotes based on the biochemical characteristics of leukocyte alpha-l-iduronidase. Arch Med Res 2002, 33:20-24.
20. Michelin K., Wajner A., Bock H., et al. Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers. Clin Chim Acta 2005, 362:101-109.
21. Michelin K., Wajner A., Goulart Lda S., et al. Biochemical study on beta-glucosidase in individuals with Gaucher's disease and normal subjects. Clin Chim Acta 2004, 343:145-153.
22. Wajner A., Michelin K., Burin M.G., et al. Comparison between the biochemical properties of plasma chitotriosidase from normal individuals and from patients with Gaucher disease, GM1-gangliosidosis, Krabbe disease and heterozygotes for Gaucher disease. Clin Biochem 2007, 40:365-369.
23. Wajner A., Michelin K., Burin M.G., et al. Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases. Clin Biochem 2004, 37:893-897.
24. Campos D., Monaga M., Gonzalez E.C., Herrera D. Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of l-iduronidase from dried blood spots. Clin Chim Acta 2013, 430C:24-27.
25. Skoog W.A., Beck W.S. Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes. Blood 1956, 11:436-454.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
27. Muller K.B., Rodrigues M.D., Pereira V.G., Martins A.M., D'Almeida V. Reference values for lysosomal enzymes activities using dried blood spots samples - a Brazilian experience. Diagn Pathol 2010, 5:65.
28. Olivova P., van der Veen K., Cullen E., et al. Effect of sample collection on alpha-galactosidase A enzyme activity measurements in dried blood spots on filter paper. Clin Chim Acta 2009, 403:159-162.
29. Lukacs Z., Nieves Cobos P., Keil A., et al. Dried blood spots in the diagnosis of lysosomal storage disorders - possibilities for newborn screening and high-risk population screening. Clin Biochem 2011, 44:476.
30. Castilhos C.D., Mezzalira J., Goldim M.P., et al. Determination of the lysosomal hydrolase activity in blood collected on filter paper, an alternative to screen high risk populations. Gene 2014, 536:344-347.
31. Hoffmann B., Georg Koch H., Schweitzer-Krantz S., Wendel U., Mayatepek E. Deficient alpha-galactosidase A activity in plasma but no Fabry disease-a pitfall in diagnosis. Clin Chem Lab Med 2005, 43:1276-1277.
32. Andrade J., Waters P.J., Singh R.S., et al. Screening for Fabry disease in patients with chronic kidney disease: limitations of plasma alpha-galactosidase assay as a screening test. Clin J Am Soc Nephrol 2008, 3:139-145.
33. Berg J.M., Tymoczko J.L., Stryer L. Enzymes: basic concepts and kinetics. Biochemistry 2010, 211-243. WH Freeman, New York.